{
    "organizations": [],
    "uuid": "c1e39d4194b78a5ebd50438989ac2c418fe9c2e1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ani-pharmaceuticals-announces-appr/brief-ani-pharmaceuticals-announces-approval-of-morphine-sulfate-oral-solution-idUSFWN1RV0KF",
    "ord_in_thread": 0,
    "title": "BRIEF-ANI Pharmaceuticals Announces Approval Of Morphine Sulfate Oral Solution",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - ANI Pharmaceuticals Inc:\n* ANI PHARMACEUTICALS ANNOUNCES APPROVAL OF MORPHINE SULFATE ORAL SOLUTION\n* ANI PHARMACEUTICALS INC - RECEIVED APPROVAL FROM U.S. FDA OF ITS ANDA FOR MORPHINE SULFATE ORAL SOLUTION 10MG/5ML, 20MG/5ML AND 100MG/5ML Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-18T20:35:00.000+03:00",
    "crawled": "2018-04-18T15:47:34.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "ani",
        "pharmaceutical",
        "inc",
        "ani",
        "pharmaceutical",
        "announces",
        "approval",
        "morphine",
        "sulfate",
        "oral",
        "solution",
        "ani",
        "pharmaceutical",
        "inc",
        "received",
        "approval",
        "fda",
        "anda",
        "morphine",
        "sulfate",
        "oral",
        "solution",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}